CLINICAL_TRIALS ClinicalTrials.gov record update

Demonstrate Lot-to-lot Consistency of Final Production Method of GSK Biologicals' Hib-MenAC Vaccine Mixed Extemporaneously With Tritanrix™-HepB & Demonstrate Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Healthy Infants at 2, 4 and 6 Months

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00197275
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:25.161758+00:00
Published At: 2016-10-07T00:00:00+00:00
Record Updated At: 2016-10-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Tetanus", "Hepatitis B", "Haemophilus Influenzae Type b", "Whole Cell Pertussis", "Diphtheria"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-10-07"
protocolSection.identificationModule.nctId: "NCT00197275"
protocolSection.identificationModule.officialTitle: "Demonstrate Lot-to-lot Consistency of Final Production Method of GSK Biologicals\u0027 Hib-MenAC Vaccine Mixed Extemporaneously With Tritanrix\u2122-HepB \u0026 Demonstrate Its Non-inferiority vs Tritanrix\u2122-HepB/Hiberix\u2122 in Healthy Infants at 2, 4 and 6 Months"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.